Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis

Results suggest similar diagnostic performance of simplified CVS methods and OCB. Ongoing studies will refine whether CVS could be used in replacement or in conjunction with OCB.

Authors

Institutions

Publication Details

Journal
Multiple Sclerosis Journal
Published
2024-09-01
DOI
https://doi.org/10.1177/13524585241271988
Citations
16
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
6.80

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis

Daniel Pelletier, Eduardo Caverzasi, Jiwon Oh, Léorah Freeman et al.
16 citations
Multiple Sclerosis Journal
Multiple Sclerosis Research Studies
6.80
article

Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis

Daniel Pelletier, Eduardo Caverzasi, Jiwon Oh, Léorah Freeman, Andrew J Solomon, Daniel Ontaneda, Bruce Cree, J. Andrew Derbyshire, Daniel S. Reich, Praneeta Raza, Erin E. Longbrake, Melissa L. Martin, Russell Taki Shinohara, Lynn Daboul, Christina Azevedo, Matthew K. Schindler, Carly M. O’Donnell, Quy Cao, Karlo Toljan, Elias S. Sotirchos, Peter A. Calabresi, Roland G. Henry, Nancy L. Sicotte, Nico Papinutto, Amit Bar‐Or, Pascal Sati, Rohini Samudralwar, Paulo Rodrigues
article en
16 citations

Abstract

Results suggest similar diagnostic performance of simplified CVS methods and OCB. Ongoing studies will refine whether CVS could be used in replacement or in conjunction with OCB.

Multiple Sclerosis JournalVol. 30(10)
University of Vermont (US), University of Southern California (US), Cedars-Sinai Medical Center (US), Brigham and Women's Hospital (US), St. Michael's Hospital (CA), National Institutes of Health (US), Cleveland Clinic (US), Johns Hopkins University (US), University of California, San Francisco (US), University of Toronto (CA), University of Pavia (IT), Yale University (US), Cleveland Clinic Lerner College of Medicine (US), National Institute of Neurological Disorders and Stroke (US), Penn Center for AIDS Research (US), National Institute of Mental Health (US), University of Pennsylvania (US), The University of Texas at Austin (US), The University of Texas Health Science Center at Houston (US)
Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, GlaxoSmithKline, Sanofi, Biogen, Alexion Pharmaceuticals, Celgene, TG Therapeutics, Race to Erase MS, Atara Biotherapeutics, Horizon Therapeutics, Multiple Sclerosis Society, Idorsia Pharmaceuticals, MedDay Pharmaceuticals, National Institutes of Health, Genentech, EMD Serono, Sanofi Genzyme, National Institute of Neurological Disorders and Stroke
Good health and well-being
Openalex Percentile: Top 3%
Multiple Sclerosis Research Studies
6.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.